Endovascular Treatment Devices Market Expands Driven by Rising Cardiovascular Disease Prevalence and Technological Advancements

The Endovascular Treatment Devices Market Size is valued at 3486.16 Million in 2024 and is predicted to reach 8398.23 Million by the year 2034 at a 9.4% CAGR during the forecast period for 2025-2034.

Global Endovascular Treatment Devices Market 2025-2034 full Research Repot latest version is now available.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1364

Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Endovascular Treatment Devices market are:
• Rising Prevalence of Cardiovascular Disease
• Increase in Prevalence of Abdominal Aortic Aneurysm (AAA)
• Rising Awareness and Acceptance of Minimally Invasive Procedures

The following are the primary obstacles to the Endovascular Treatment Devices market's expansion:
• High Costs of Endovascular Operations & Devices
• Limitations Associated with the Use of Endovascular Devices

Future expansion opportunities for the global Endovascular Treatment Devices market include:
• Advancement in Endovascular Treatment Technology
• Rising demand for Stent-graft in Aortic Aneurysm Repair Procedures
• Rise in Adoption of Polymer Material in Endovascular Abdominal Aortic Aneurysm Repair Treatment

Key Industry Insights & Findings from the report:
• The growing number of patients seeking treatment for these disorders increases the demand for endovascular treatment devices, which provide less invasive options with faster recovery periods than standard surgery.
• These developments are especially significant in the treatment of abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA), resulting in improved patient outcomes and a larger market.
• North America is expected to have the largest market share in 2024 due to an increase in surgical procedures and a rise in preference for endovascular devices.
• The high cost can be a substantial impediment for both healthcare professionals and patients, limiting total market adoption.

Market Analysis:
The endovascular treatment devices market is projected to experience growth during the forecast period, driven by factors such as the rising geriatric population, the growing prevalence of cardiovascular diseases, advancements in endovascular technologies, and increased research and development investments by industry stakeholders. However, market expansion is hindered by challenges such as the high cost of endovascular procedures, limited awareness in economically disadvantaged regions, and a shortage of qualified surgeons capable of performing these specialized surgeries.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

List of Prominent Players in the Endovascular Treatment Devices Market:
• Cardinal Health
• Endospan
• Geting AB
• Bosten Scientific Corporation
• Inspire MD
• Japan Lifeline Co., Ltd.
• Medtronic
• Lombord Medical
• Penumbra, Inc.
• Terumo Corporation

Recent Developments:
• In October 2024, BD released an Intraosseous Vascular Access System that provides fast access to the vascular system. This method provides rapid access to the circulatory system for both adult and pediatric patients.
• In September 2024, B. Braun gained FDA authorization for the Introcan Safety 2Deep Access IV Catheter, which aids in multi-access blood management over greater distances.
• In September 2023, Orchestra BioMed gained FDA clearance for an IDE to begin the BACKBEAT pivotal trial of Backbeat CNT for the treatment of hypertension in pacemaker patients.
• Gore announced in January 2024 that the Gore Excluder thoracoabdominal branch end prosthesis (TAMBE) has received FDA clearance. The business claims that this is the first off-the-shelf endovascular treatment designed to address complex aneurysmal problems affecting the visceral aorta.

Endovascular Treatment Devices Market Dynamics:
Market Drivers: Increasing Prevalence of Cardiovascular Diseases
The global market for endovascular treatment devices is experiencing significant expansion, driven by the rising incidence of cardiovascular diseases, which result in an estimated 17.9 million deaths annually, according to the World Health Organization. Conditions such as coronary artery disease, peripheral artery disease, and acute ischemic strokes are driving demand for minimally invasive devices, including stent grafts, catheters, and thrombectomy devices. Additionally, the increasing prevalence of abdominal aortic aneurysms worldwide is accelerating the adoption of minimally invasive procedures like percutaneous endovascular aneurysm repair (PEVAR) and transcatheter aortic valve repair (TAVR), which offer shorter recovery times and reduced hospital stays. Technological advancements and ongoing research and development efforts are enhancing device efficacy and safety, particularly in response to the healthcare needs of an aging population, while rising healthcare expenditures in developed nations further fuel market growth.

Challenges: High Costs of Endovascular Procedures and Devices
The high costs associated with endovascular procedures and devices present a significant barrier to market adoption, affecting both healthcare providers and patients. Additionally, the shortage of qualified surgeons capable of performing these complex procedures limits market expansion, while stringent regulatory requirements slow the introduction of innovative devices, hindering progress in the industry.

Regional Trends: North America to Experience the Highest Growth
The North American market for endovascular treatment devices is expected to capture the largest revenue share in the near future. The market's growth is attributed to the increased number of surgical procedures and the rising demand for advanced endovascular devices among healthcare professionals, prompting major companies to focus on the development of cutting-edge medical devices in the region. Contributing factors such as the prevalence of obesity and dietary-related issues, along with the launch of new products by leading manufacturers, will further drive the growth of the endovascular treatment device market. Additionally, favorable reimbursement policies for endovascular procedures are expected to stimulate further market expansion in North America.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1364

Segmentation of Endovascular Treatment Devices Market-
By Product Type-
• Percutaneous Endovascular Aneurysm Repair (EVAR)
• Fenestrated EVAR
• Aortic Stents Biodegradable Stents
• Self- Expanding Nitinol Stents
• Thoracic Aortic Aneurysm Grafts
• Other Devices
By Procedure-
• Ballon Angioplasty
• Angioplasty With Stent Replacement
• Drug-Eluting Stents Renal Artery Angioplasty and Stenting Carotid Artery
• Thrombosis
• Renal Artery Angioplasty and Stenting
• Transfemoral Carotid Artery Revascularization
• Intravascular Brachytherapy
• Carotid Artery Stenting
By Crop Source
• Pulmonary
• Vascular
• Cardiology Surgery
• Neurology
• Radiology
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/global-endovascular-treatment-devices-market-/1364

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.